# (CDXC)

> (CDXC) trades at $7.85 as of 7:53:29 PM EDT on Mar 18, 2025, with 1.0 days to cover in short interest.

Canonical: https://massive.com/quote/cdxc
Data as of: 2025-03-18T23:53:29.609Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$7.85**
As of 7:53:29 PM EDT on Mar 18, 2025 · 15-minute delayed

## Key statistics

Today's trading snapshot for CDXC: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $7.75 – $7.92 |
| Open | $7.91 |
| Prev close | — |
| Volume | 541.87K |
| Market cap | — |
| Shares out | — |

## Insider trading

[(CDXC) insider trading](https://massive.com/quote/cdxc/insider-trading.md): open-market Form 4 buys and sells by  insiders over the last 12 months.

## 8-K filings

Material corporate events  has disclosed to the SEC on Form 8-K.

- Nov 4, 2026 · [Quarterly earnings](https://massive.com/quote/sec-filings/8-k/earnings-releases.md)
  “On November 4, 2026, Niagen Bioscience, Inc. (the "Company") issued a press release announcing its earnings for the quarter ended September 30, 2026.”
- Aug 4, 2026 · Investor presentation
  “On August 4, 2026, the Company released a corporate presentation which it made available on its website.”
- Jun 29, 2026 · Annual meeting results
  “Set forth below are the results of the matters submitted for a vote of stockholders at the Company's 2026 Annual Meeting. Proposal 1 — Election of directors. The following directors were elected to serve until the Company's 2027 Annual Meeting of Stockholders...”
- May 6, 2026 · Investor presentation
  “On May 6, 2026, the Company released a corporate presentation which it made available on its website.”
- Mar 19, 2026 · [Share repurchase program](https://massive.com/quote/sec-filings/8-k/share-buybacks.md)
  “the Board of Directors (the "Board") of Niagen Bioscience, Inc. (the "Company") approved an increase in the authorization under the Company's share repurchase program. Under the amended authorization, the Company may repurchase up to $20.0 million of its outstanding common stock, representing an increase from the previously authorized $10.0 million share repurchase program approved by the Board on October 31, 2025.”

## Dividend history and stock splits

's recent dividend payments and stock splits.

### Dividends

No recent dividends.

### Splits

- 1-for-3 · Apr 13, 2016

## CDXC short interest

How heavily CDXC is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 1.0 |
| Short interest | 1.89M |
| Avg volume | 2.86M |

As of Mar 14, 2025 · reported to FINRA twice monthly.

## CDXC news

The latest news and headlines about  (CDXC).

- [Chlorinated Isopropane Market Set for 4.9% CAGR Growth, Hitting USD 496.0 Million by 2035 \| Fact.MR Report](https://www.globenewswire.com/news-release/2025/03/19/3045225/0/en/Chlorinated-Isopropane-Market-Set-for-4-9-CAGR-Growth-Hitting-USD-496-0-Million-by-2035-Fact-MR-Report.html) · GlobeNewswire Inc. · Mar 19, 2025 · neutral sentiment
- [ChromaDex (CDXC) Up as Ataxia Candidate Gets Orphan Drug Tag](https://www.zacks.com/stock/news/2286094/chromadex-cdxc-up-as-ataxia-candidate-gets-orphan-drug-tag) · Zacks Investment Research · Jun 10, 2024
- [Precision BioSciences (DTIL) Soars 13.4%: Is Further Upside Left in the Stock?](https://www.zacks.com/stock/news/2248894/precision-biosciences-dtil-soars-134-is-further-upside-left-in-the-stock) · Zacks Investment Research · Apr 2, 2024
- [Kiniksa Pharmaceuticals, Ltd. (KNSA) Q4 Earnings and Revenues Surpass Estimates](https://www.zacks.com/stock/news/2233045/kiniksa-pharmaceuticals-ltd-knsa-q4-earnings-and-revenues-surpass-estimates) · Zacks Investment Research · Feb 28, 2024
- [ChromaDex (CDXC) Reports Q2 Loss, Tops Revenue Estimates](https://www.zacks.com/stock/news/2134548/chromadex-cdxc-reports-q2-loss-tops-revenue-estimates) · Zacks Investment Research · Aug 9, 2023

## About 

| Measure | Value |
| --- | --- |

## FAQ

### What is the (CDXC) stock price today?

(CDXC) is trading at $7.85 as of 7:53:29 PM EDT on Mar 18, 2025. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is ?

(CDXC) is a security listed on a US exchange.

### What is the short interest in CDXC?

As of Mar 14, 2025, CDXC has 1.89M shares short and 1.0 days to cover.

## Live data

Prices here are 15-minute delayed. For real-time CDXC quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=CDXC`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [(CDXC) insider trading](https://massive.com/quote/cdxc/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
